European Medical Journal

New International Guidelines Set Standard for Bronchiectasis Care

ERS issues new bronchiectasis guidelines to improve patient care, standardise treatment, and reduce variability in global ...
The American Journal of Managed Care

Brensocatib Becomes First FDA-Approved Therapy for Bronchiectasis

Brensocatib is the first approved therapy for non–cystic fibrosis bronchiectasis and the first dipeptidyl peptidase 1 inhibitor for neutrophil-mediated diseases. The ASPEN trial showed brensocatib ...
Healio

Bronchiectasis increases risk for lung cancer regardless of smoking history

Please provide your email address to receive an email when new articles are posted on . The population-based cohort study included 3,858,422 participants from the 2009 National Health Screening ...
MedPage Today

Mucus-Thinning Strategies Fail for Bronchiectasis, Study Shows

Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial showed. In the two-by-two factorial trial testing hypertonic saline and ...
Pharm Exec

FDA Approves Insmed’s Brinsupri as First Treatment for Non-Cystic Fibrosis Bronchiectasis

Brinsupri is the first FDA-approved treatment for non-cystic fibrosis bronchiectasis, targeting patients aged 12 and older. The ASPEN and WILLOW trials showed Brinsupri significantly reduces ...